Department of Internal Medicine/Cardiology, University of Leipzig Heart Center, Germany.
Am J Cardiol. 2010 Sep 1;106(5):605-11. doi: 10.1016/j.amjcard.2010.04.010.
The aim of this study was to examine the effect of coronary collateral flow before reperfusion on long-term clinical prognosis in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. We studied 235 patients with STEMI within 12 hours after symptom onset. All patients had Thrombolysis In Myocardial Infarction grade < or =1 flow before percutaneous coronary intervention. Collateral flow was graded according to the Rentrop classification. Patients were categorized as having absent or poor collateral flow to the infarct-related artery (group A) or significant flow (group B). In 166 patients there was absent or weak collateral flow (group A), whereas 69 had significant flow (group B). Long-term follow-up was available in 227 patients (97%) at a median of 797 days. Overall, 25 patients died during the follow-up period, 22 patients (13.8%) in group A and 3 patients (4.4%) in group B (p = 0.04). A total of 12 (7.5%) nonfatal recurrent myocardial infarctions occurred in group A compared to 2 (2.9%) in group B (p = 0.18). The combined major adverse cardiovascular event end point (death or nonfatal reinfarction) showed a significantly lower event rate in group B (p = 0.02). Extensive collateral flow at baseline was a significant predictor for a favorable long-term clinical outcome on multivariable analysis after adjustment for established prognostic markers. In conclusion, the presence of a well-developed collateral network before mechanical reperfusion in patients with STEMI is associated with improved long-term survival and lower major adverse cardiovascular event rates.
本研究旨在探讨急性 ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)前再灌注前冠状动脉侧支循环血流对长期临床预后的影响。我们研究了 235 例 STEMI 患者,这些患者在症状发作后 12 小时内接受了治疗。所有患者在接受直接 PCI 前都有 Thrombolysis In Myocardial Infarction 分级≤1 级的血流。侧支循环血流根据 Rentrop 分级进行分级。将患者分为梗死相关动脉无或低侧支循环血流(组 A)或有显著侧支循环血流(组 B)。在 166 例患者中,存在无或弱侧支循环血流(组 A),而 69 例患者存在显著侧支循环血流(组 B)。中位随访时间为 797 天,共 227 例患者(97%)获得了长期随访。在随访期间,共有 25 例患者死亡,其中 22 例(13.8%)在组 A,3 例(4.4%)在组 B(p = 0.04)。组 A 中有 12 例(7.5%)非致命性再发心肌梗死,而组 B 中有 2 例(2.9%)(p = 0.18)。组 B 的主要不良心血管事件终点(死亡或非致命性再梗死)发生率明显较低(p = 0.02)。多变量分析调整了既定的预后标志物后,基线时广泛的侧支循环血流是长期临床预后良好的显著预测因素。总之,STEMI 患者机械再灌注前存在发达的侧支循环网络与长期生存率的提高和主要不良心血管事件发生率的降低相关。